items
Fears extra expense and paperwork caused by Brexit will make Britain unattractive to global drugmakers.
|
types
◈ news ×1
related tags
◈ disruption ×1
◈ medicine ×1
◈ research ×1
◈ EMA ×1
◈ MHRA ×1
◈ NICE ×1
|